BR9916893A - Tratamento - Google Patents
TratamentoInfo
- Publication number
- BR9916893A BR9916893A BR9916893-6A BR9916893A BR9916893A BR 9916893 A BR9916893 A BR 9916893A BR 9916893 A BR9916893 A BR 9916893A BR 9916893 A BR9916893 A BR 9916893A
- Authority
- BR
- Brazil
- Prior art keywords
- hepatitis
- treatment
- virus
- vaccine
- antiviral agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9900630 | 1999-01-12 | ||
PCT/EP1999/010295 WO2000041463A2 (en) | 1999-01-12 | 1999-12-21 | Combination of hepatitis b vaccine with antiviral agents |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9916893A true BR9916893A (pt) | 2001-11-20 |
Family
ID=10845878
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9916893-6A BR9916893A (pt) | 1999-01-12 | 1999-12-21 | Tratamento |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1140163A2 (ko) |
JP (1) | JP2002534438A (ko) |
KR (1) | KR20010090011A (ko) |
CN (1) | CN1391482A (ko) |
AR (1) | AR022250A1 (ko) |
AU (1) | AU760574B2 (ko) |
BR (1) | BR9916893A (ko) |
CA (1) | CA2359110A1 (ko) |
CO (1) | CO5241355A1 (ko) |
CZ (1) | CZ20012544A3 (ko) |
HK (1) | HK1041434A1 (ko) |
HU (1) | HUP0105070A2 (ko) |
IL (1) | IL144186A0 (ko) |
NO (1) | NO20013337L (ko) |
NZ (1) | NZ512890A (ko) |
PL (1) | PL349347A1 (ko) |
TR (1) | TR200102024T2 (ko) |
WO (1) | WO2000041463A2 (ko) |
ZA (1) | ZA200105690B (ko) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI1077722T1 (sl) | 1998-05-22 | 2007-02-28 | Ottawa Health Research Inst | Metode in produkti za induciranje sluznicne imunosti |
AU4932199A (en) | 1998-07-31 | 2000-02-21 | Haruo Sugiyama | Cancer antigens based on tumor suppressor gene wt1 product |
US20040097703A1 (en) | 2001-03-22 | 2004-05-20 | Haruo Sugiyama | Wt1 modified peptide |
US20050002951A1 (en) * | 2001-09-28 | 2005-01-06 | Haruo Sugiyama | Novel method of inducing antigen-specific t cells |
US8735357B2 (en) | 2001-09-28 | 2014-05-27 | International Institute Of Cancer Immunology, Inc. | Method of inducing antigen-specific T cells |
TWI275392B (en) * | 2002-04-08 | 2007-03-11 | Bristol Myers Squibb Co | Low dose liquid entecavir formulations and use |
PT2241325E (pt) | 2002-10-29 | 2012-04-12 | Coley Pharm Gmbh | Utilização de oligonucleótidos cpg no tratamento de infecção com vírus da hepatite c |
WO2004053104A2 (en) | 2002-12-11 | 2004-06-24 | Coley Pharmaceutical Group, Inc. | 5’ cpg nucleic acids and methods of use |
CN100443117C (zh) * | 2003-05-13 | 2008-12-17 | 深圳康泰生物制品股份有限公司 | 一种治疗性乙型肝炎的疫苗制剂、其制备方法及其用途 |
US8541167B2 (en) | 2004-06-03 | 2013-09-24 | Saint Louis University | Methods and compositions for vaccination |
AR065504A1 (es) * | 2007-02-28 | 2009-06-10 | Ct Ingenieria Genetica Biotech | Terapia combinada para el tratamiento de la hepatitis b cronica. uso. |
WO2020134682A1 (zh) * | 2018-12-24 | 2020-07-02 | 南京远大赛威信生物医药有限公司 | 用于治疗乙型肝炎的药物制剂及其制备方法和用途 |
CN117120088A (zh) * | 2021-04-07 | 2023-11-24 | 电化株式会社 | 佐剂活性增强剂和佐剂组合物 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE159031T1 (de) * | 1989-07-25 | 1997-10-15 | Smithkline Biolog | Antigene sowie verfahren zu deren herstellung |
ES2273482T3 (es) * | 1998-03-09 | 2007-05-01 | Glaxosmithkline Biologicals S.A. | Composiciones de vacunas combinadas. |
-
1999
- 1999-12-21 TR TR2001/02024T patent/TR200102024T2/xx unknown
- 1999-12-21 HU HU0105070A patent/HUP0105070A2/hu unknown
- 1999-12-21 IL IL14418699A patent/IL144186A0/xx unknown
- 1999-12-21 WO PCT/EP1999/010295 patent/WO2000041463A2/en not_active Application Discontinuation
- 1999-12-21 CN CN99816471A patent/CN1391482A/zh active Pending
- 1999-12-21 AU AU21009/00A patent/AU760574B2/en not_active Ceased
- 1999-12-21 EP EP99965531A patent/EP1140163A2/en not_active Withdrawn
- 1999-12-21 BR BR9916893-6A patent/BR9916893A/pt not_active IP Right Cessation
- 1999-12-21 KR KR1020017008833A patent/KR20010090011A/ko not_active Application Discontinuation
- 1999-12-21 NZ NZ512890A patent/NZ512890A/en unknown
- 1999-12-21 CZ CZ20012544A patent/CZ20012544A3/cs unknown
- 1999-12-21 JP JP2000593088A patent/JP2002534438A/ja active Pending
- 1999-12-21 CA CA002359110A patent/CA2359110A1/en not_active Abandoned
- 1999-12-21 PL PL99349347A patent/PL349347A1/xx not_active Application Discontinuation
-
2000
- 2000-01-11 AR ARP000100107A patent/AR022250A1/es not_active Application Discontinuation
- 2000-01-12 CO CO00001261A patent/CO5241355A1/es not_active Application Discontinuation
-
2001
- 2001-07-05 NO NO20013337A patent/NO20013337L/no not_active Application Discontinuation
- 2001-07-11 ZA ZA200105690A patent/ZA200105690B/xx unknown
-
2002
- 2002-02-19 HK HK02101211.9A patent/HK1041434A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
IL144186A0 (en) | 2002-05-23 |
HUP0105070A2 (hu) | 2002-04-29 |
WO2000041463A3 (en) | 2000-11-09 |
NO20013337L (no) | 2001-08-17 |
NZ512890A (en) | 2003-09-26 |
CZ20012544A3 (cs) | 2002-01-16 |
KR20010090011A (ko) | 2001-10-17 |
TR200102024T2 (tr) | 2001-12-21 |
PL349347A1 (en) | 2002-07-15 |
JP2002534438A (ja) | 2002-10-15 |
NO20013337D0 (no) | 2001-07-05 |
WO2000041463A2 (en) | 2000-07-20 |
CN1391482A (zh) | 2003-01-15 |
ZA200105690B (en) | 2002-09-25 |
AU2100900A (en) | 2000-08-01 |
AU760574B2 (en) | 2003-05-15 |
EP1140163A2 (en) | 2001-10-10 |
CO5241355A1 (es) | 2003-01-31 |
AR022250A1 (es) | 2002-09-04 |
CA2359110A1 (en) | 2000-07-20 |
HK1041434A1 (zh) | 2002-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI317735B (en) | Methods and compositions for treating hepatitis c virus | |
BR9916893A (pt) | Tratamento | |
TR199903053T2 (xx) | Benzimidazol t�revleri. | |
BR0011433B1 (pt) | Compostos de imidazoquinolinas substituídas com sulfonamida e sulfamida e composição farmaceutica cotendo os mesmos | |
BR0206614A (pt) | Composto, composição farmacêutica, método para inibir a polimerase viral de rna dependente de rna e/ou inibir a replicação viral de rna dependente de rna, método para tratar uma infecção viral de rna dependente de rna, e, uso de um composto | |
BR0107972A (pt) | Uso de uma proteìna ou polinucleotìdeo tat do hiv, nef do hiv, ou tat do hiv ligado(a) a uma proteìna ou polinucleotìdeo nef do hiv (nef-tat), e de uma proteìna ou polinucleotìdeo gp120 do hiv, método para imunizar um ser humano contra o hiv, e, composição de vacina para o uso humano | |
BR0209658A (pt) | Derivados de 4-amino-5-fenil-7-1ciclobutil-pirrolo [2,3-d] pirimidina | |
BR9811121A (pt) | Produto, composição farmacêutica, e uso de um produto | |
NO20034204D0 (no) | Farmasöytiske kombinasjoner til behandling av kreft | |
HRP20040059B1 (en) | Treatment of nail infections with no | |
AR002255A1 (es) | Una composicion que comprende una formulacion de antigeno microfluidizada y usos de dicha formulacion. | |
BR0108435A (pt) | Formulação e uso de entecavir de baixa dose | |
AR030068A1 (es) | Composiciones farmaceuticas para el tratamiento de condiciones dolorosas, inflamatorias y ulcerosas de superficies epiteliales humedas como por ejemplo mucositis, estomatitis y sindrome de behcet | |
HUP9904092A2 (hu) | Gyógyszerkészítmény HIV és rák kezelésére valamint eljárás előállítására | |
HUP0202502A2 (hu) | Virális fertőzőképességet blokkoló peptidek és eljárások ezek alkalmazására | |
ES2188995T3 (es) | Uso de un inhibidor de la h+, k+-atpasa en el tratamiento de los polipos nasales. | |
PE61699A1 (es) | Composicion farmaceutica de lamivudina | |
ES2041243T3 (es) | Aplicacion de por lo menos un principio activo inhibidor o destructor de por lo menos un ser vivo unicelular o virus. | |
BR0317539A (pt) | Métodos e composições para o tratamento de infecções por vìrus da herpes usando inibidores seletivos da ou ciclooxigenase-2 ou inibidores da ciclooxigenase-2 em combinação com agentes antivirais | |
BR0206775A (pt) | Uso de um medicamento para tratar um indivìduo infectado com hiv, por combinação de imunização com interrupção estruturada do tratamento anti-retrovirótico | |
ATE395064T1 (de) | Kombinationspräparate von 3-n- formylhydroxylaminopropylphosphonsäurederivaten oder 3-n- acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen | |
NO20055243L (no) | Interferon beta ved alvorlig akutt respiratorisk syndrom (SARS) | |
BR9809127A (pt) | Combinação, formulação farmacêutica, processo para o tratamento de uma infecção por hiv em um animal infectado, uso de (-) -(1s,4r)-4-[2-amino-6-(ciclopropil amino)-9h-purin-9-il)-2-ciclopenteno-1-metanol, e, pacote de paciente | |
CL2004001291A1 (es) | Composicion farmaceutica que comprende compuestos carbociclicos y heterociclicos; y su uso para el tratamiento o profilaxis de la infeccion por influenza. | |
AR025340A1 (es) | Composiciones farmaceuticas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6O E 7O ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1913 DE 04/09/2007. |